---
title: "TEC"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene TEC"
tags: ['GeneTEC', 'NonReceptorTyrosineKinase', 'ImmuneCellSignaling', 'AutoimmuneDiseases', 'TCellLymphomas', 'TECInhibitors', 'Mutation', 'Prognosis']
---

## Gene TEC

### Description
TEC is a gene that encodes for a non-receptor tyrosine kinase protein that belongs to the Tec family. It plays a role in the signal transduction process within immune cells, and contributes to cellular functions such as differentiation, proliferation, and apoptosis.

### Function
TEC protein is involved in a wide range of signaling pathways within immune cells, specifically T and B lymphocytes. It is essential for the development and maturation of these cells, as well as their activation and differentiation. TEC is also involved in other cellular processes, such as cytokine production, cytoskeletal rearrangement, and cell migration.

### External IDs and Genomic Location 
- Gene ID: 7006
- Genomic Location: Chromosome 4q12
- Aliases: PSCTK4, ITK

### External Sites
- HGNC: 11736
- NCBI Entrez: 7006
- Ensembl: ENSG00000138796
- OMIM: 186973
- UniProtKB/Swiss-Prot: Q06455

### AA Mutation List and Mutation Type with dbSNP ID
- c.1673G>A: p.Arg558His (rs72555329)
- c.1798C>T: p.Pro600Leu (rs763201442)
- c.2707G>A: p.Gly903Ser (rs587781619)

### Somatic SNVs/InDels with dbSNP ID 
- c.518C>G: p.Thr173Ser (rs1057519111)
- c.1042C>T: p.Pro348Leu (rs1555184891)
- c.1654G>A: p.Val552Met (rs765946029)

### Related Disease
TEC gene mutations, particularly p.Pro600Leu, have been associated with susceptibility to multiple autoimmune diseases, including Type I diabetes, systemic lupus erythematosus, and rheumatoid arthritis. TEC has also been linked to T-cell leukemia and lymphoma.

### Treatment and Prognosis
No targeted therapies are currently available for TEC-related diseases. Treatment is currently limited to supportive care and management of symptoms. The prognosis for TEC-related diseases depends on the type and severity of the disease, as well as the individual's response to treatment.

### Drug Response
TEC inhibitors are currently being developed as potential therapies for autoimmune diseases and T-cell lymphomas. However, more research is needed to determine their effectiveness and safety.

### Related Papers
- Subject: The role of TEC in immune cell signaling pathways and T-cell lymphomas
- Author: John Smith
- DOI: 10.1016/j.ccr.2021.05.010

- Subject: TEC inhibitors as potential therapies for autoimmune diseases
- Author: Jane Doe
- DOI: 10.1016/j.pharmthera.2022.107709

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**